Therapeutics - Dyslipidemia Part 2 Flashcards
(63 cards)
patient on a statin is not reaching LDL goal
what do we do next
1st - assess adherence!
if they are adherent, add ezetimibe. could add bile acid sequesterant, but prolly not
if patient is still not at LDL goal with statin + zetia (or bile acid resin)
what do we do next? what if this doesnt work?
could add PCSK9 inhibitor, bempedoic acid (nexletol), or inclisiran (leqvio)
if this doesnt work – refer to lipid specialist – may need MAB (Evkeeza/evinacumab) - HOWEVER, this is very expensive and very last line
true or false
zetia cannot be combined with bempedoic acid
FALSE - it can
true or false
ezetimibe is not recommended to be used alone
TRUE
it’s well tolerated, but not very effective by itself
typically added to statin therapy
true or false
ezetimibe must be taken with food
false - doesnt matter
counseling point if patient is on ezetimibe and a bile acid sequesterant
take the zetia either 2 hours before or 4 hours after
3 available bile acid sequestrants
which comes as a tab in which the patient has to take 3 tabs BID (VERY INCONVENIENT)
colesevelam (lot of tabs)
cholestyramine
colestipol
should cholestyramine be taken with food
yes
true or false
bile acid sequestrants are not recommended to be used alone
TRUE - dont do too much alone
can bile acid sequestrants be combined with statins
yes - just cant take at same time
why are bile acid sequestrants not really used
no CV outcome trials, and there’s a lot of AE
if patient can’t take zetia for some reason, would a PCKS9 inhibitor or a bile acid sequestrant make more sense
typically PCKS9 inhibitor, unless cost is an issue
name some AE of bile acid sequestrants in general
constipation, nausea, dyspepsia
increased triglycerides!
true or false
bile acid sequestrants increase triglycerides
true
name 3 DDI of colesevelam with other drugs
-decreased phenytoin levels (increased seizures)
-decreased INR for warfarin (bleed)
-increased TSH in patients getting thyroid HRT
name 2 PCSK9 inhibitors
both can be given Q2 weeks
which can be given only Q month?
alirocumab ( praluent)
evolocumab (repatha)
repatha
name some AE of the PCSK9 inhibitors
not many - just miled injection site reactions, myalgia
however, no long term safety data - potential cognitive effects
repatha + efgartigimod interaction
decreased repatha levels
MOA bempedoic acid (nexletol)
how is the MOA an advantage?
ATP citrate lyase inhibitor
may be used in patients who get myalgia from statins
true or false
nexletol does not have significant LDL reduction on its own
TRUE
like ezetimibe, really only useful with statin, or all 3 can even be used together
true or false
nexletol is not as good as statins and PCSK9 inhibitors at reducing CV outcomes
TRUE
PCKS9 inhibitors are definitely a better option if the patient is statin intolerant
name some AE of bempedoic acid (nexletol) and who we definitely do not wawnt to give this drug to
increases uric acid - (by inhib OAT 2) so definitely dont give to gout patients!!!!
also risk of gallstones
increased SCr and LFT
tendon rupture
lot of SE
true or false
bempedoic acid should not be considered 1st line, but is a possible option in shared decision making
true
molecular wise, what is Inclisiran (Leqvio)
a siRNA (small interfering ribonucleic agent)